Company Profile

Galaxy Diagnostics Inc
Profile last edited on: 11/1/19      CAGE: 5LDJ0      UEI: PMCLLXJ8RME5

Business Identifier: Detection of pathogens linked to disorders affecting the joints, vascular and neurological systems
Year Founded
2009
First Award
2011
Latest Award
2018
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

7020 Kit Creek Road Suite 130
Research Triangle Park, NC 27709
   (919) 313-9672
   contact@galaxydx.com
   www.galaxydx.com
Location: Single
Congr. District: 04
County: Durham

Public Profile

Galaxy Diagnostics is structured around increasing awareness of the emerging research of bartonellosis among key stakeholders in medicine, public health and the veterinary community and to offer the best possible clinical testing for confirmation of Bartonella species bacteremia. As a social venture and a One Health company, Galaxy Diagnostics is comitted to protecting the animal-human bond through the surveillance, prevention and clinical management of diseases shared by humans and animals. Offering the best molecular and serology test options available, the firm also works with researchers and clinicians to generate new knowledge about emerging infectious diseases such as bartonellosis, borreliosis and other vector-borne diseases, providing counsel to clinicians and researchers to enable the most accurate diagnosis possible for their patients. This central goal is reflected in our corporate values and everyday interaction with patients, clinicians and researchers. Galaxy Diagnostics was orignally founded to commercialize a more sensitive test for Bartonella species infection (e.g., bartonellosis, cat scratch disease, trench fever, etc.), based on a proprietary technology called Bartonella Alpha Proteobacteria Growth Medium (BAPGM), developed by scientists at North Carolina State University’s College of Veterinary Medicine. The One Health approach recognizes that the health of people is connected to the health of animals and the environment: For every TEN infectious diseases in humans, SIX are spread from animals. The goal of One Health is to encourage collaborative efforts across multiple disciplines working locally, nationally and globally to achieve the best health for people, animals and the environment.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Key People / Management

  Amanda B Elam -- President

  Edward Breitschwerdt -- Chief Scientific Officer

  Ricardo Maggi -- Chief Technical Officer

  Patricia Mascarelli

  Jennifer C Miller

  B Robert Mozayeni -- Chief Medical Officer

Company News

There are no news available.